Stock Markets July 15, 2026 04:00 AM

Dr Martens Maintains Fiscal 2027 Guidance Citing Strong U.S. Wholesale Demand

Bootmaker says trading since April is on track; Asia shows strength while Europe holds up despite headwinds

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
DOCS

Dr Martens reiterated its fiscal 2027 outlook on July 15, pointing to healthy wholesale demand in the United States and trading that has met expectations since the start of the financial year in April. The company reported solid performance in Japan and South Korea, while European markets were broadly in line with forecasts despite a difficult consumer environment. In May the group logged a revenue decline in the EMEA region attributed to the economic effects of the Iran war. A company-compiled consensus expects adjusted pretax profit of 68 million for fiscal 2027. Shares initially rose as much as 3.8% to 75.5 pence before settling back to flat by 07:31 GMT.

Dr Martens Maintains Fiscal 2027 Guidance Citing Strong U.S. Wholesale Demand
DOCS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Dr Martens reaffirmed its fiscal 2027 guidance, citing encouraging wholesale demand in the United States.
  • Trading since the start of the financial year in April has been in line with the company's expectations; Japan and South Korea are performing well while Europe is holding steady despite a challenging consumer backdrop.
  • A company-compiled consensus expects adjusted pretax profit of 68 million for fiscal 2027; shares rose as much as 3.8% to 75.5 pence in early trade before settling flat by 07:31 GMT.

July 15 - Dr Martens confirmed on Wednesday that it is holding to its fiscal 2027 outlook, highlighting encouraging wholesale demand in its largest market, the United States. The company said trading since the start of its financial year in April has been in line with expectations.

Management pointed to strong performances in parts of Asia, with Japan and South Korea showing particularly positive demand trends. European markets, the company said, were broadly performing in line with internal expectations despite what it described as a challenging consumer backdrop.

In May, Dr Martens reported a revenue decline in the Europe, Middle East and Africa region. The company attributed the drop in part to the economic fallout from the Iran war, which it said had weighed on consumer spending across the EMEA footprint.

On the profit front, a company-compiled consensus projects adjusted pretax profit of 68 million for fiscal 2027. That figure was presented by the company as the market expectation against which current trading and outlook are being assessed.

Shares of Dr Martens moved higher in early trading, rising as much as 3.8% to 75.5 pence, before giving back those gains and trading flat by 07:31 GMT. The company provided the exchange rate used in reporting: $1 = 0.7455.


What the company highlighted

  • Trading since April has met managements expectations.
  • Wholesale demand in the United States is cited as encouraging and central to maintaining the fiscal 2027 outlook.
  • Japan and South Korea are performing well; Europe remains roughly in line with expectations despite tougher consumer conditions.

The companys update provided an operational snapshot rather than any change to full-year guidance. It emphasized regional variation in performance and noted the specific revenue pressure in EMEA tied to the Iran wars economic impacts.

Investors reacted with an intraday uptick in the stock followed by a stabilization to flat trading by the stated time, reflecting a modest market response to the companys reaffirmation of guidance and regional performance details.

Risks

  • Revenue in the EMEA region declined in May, with the company linking the weakness to the economic fallout from the Iran war - a risk to consumer spending in the region.
  • The broader European consumer environment is described as challenging, which may limit growth or margin recovery in that region.
  • Share price volatility is possible, as evidenced by the early intraday rise followed by a return to flat trading, indicating sensitivity to trading updates and regional developments.

More from Stock Markets

Wolfe Research lifts Q2 outlook for Southwest and United, flags fuel-driven Q3 risks Jul 15, 2026 Jefferies: Tokenisation Moving From Experimentation to Early Strategic Adoption in European Market Infrastructure Jul 15, 2026 U.S. Replacement Light-Vehicle Tire Shipments Rise 3.8% in June, USTMA Data Shows Jul 15, 2026 Bernstein Finds Emerging Markets Reaping Strong AI Benefits Jul 15, 2026 JPMorgan Rolls Out Major EMEA Corporate Banking Expansion, Targets Market Share Gains Jul 15, 2026